Archives of Gynecology and Obstetrics

, Volume 279, Issue 4, pp 579–581 | Cite as

Term delivery following successful treatment of choriocarcinoma with brain metastases, a case report and review of literature

  • Nadereh Behtash
  • Fariba Behnamfar
  • Bahareh Hamedi
  • Fatemeh Ramezanzadeh
Case Report

Abstract

Background

Cerebral metastases from choriocarcinoma are a poor prognostic indicator of outcome in both the World Health Organization and FIGO classification systems. Although gestational trophoblastic neoplasia has become the most curable of gynecological malignancies, failure rate among “high-risk” patients is still high despite of the use of aggressive multidrug regimens.

Case

A 27-year-old woman (G4P2Ab1) presented with hemiplegia due to brain metastases of choriocarcinoma 1 year after spontaneous abortion. She underwent craniotomy and was treated with nine courses of multiple agent etoposide, methotrexate, actinomycin- etoposide, and cisplatinum (EMA-EP) regimen combined with whole brain irradiation. She delivered a term healthy child 2 years after termination of treatment.

Conclusion

Multiagent EMA-EP chemotherapy and whole brain irradiation with craniotomy in selected patients preserves fertility and may improve a patient overall prognosis.

Keywords

Choriocarcinoma Brain metastases EMA-EP 

References

  1. 1.
    Hiramatsu Y, Masuyama H, Ishida M, Murakami K, Sakurai M (2005) Term delivery choriocarcinoma patient with brain and lung metastases successfully treated by etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristin (EMA-CO) chemotherapy. Acta Med Okayama 59(5):235–238PubMedGoogle Scholar
  2. 2.
    Jones WB, Wagner-Reiss KM, Lewis JL Jr (1991) Intracerebral choriocarcinoma. Gynecol Oncol 40(1):100CrossRefGoogle Scholar
  3. 3.
    Evans AC Jr, Soper JT, Clarke-Pearson DL, Berchuck A (1995) Central nervous system metastases of choriocarcinoma. 23 years’ experience at charing cross hospital. Gynecol Oncol 59(2):226–230. doi:10.1006/gyno.1995.0013 PubMedCrossRefGoogle Scholar
  4. 4.
    Ayhan A, Tuncer ZS, Tanir M, Erbengi A (1996) Central nervous system involvement in gestational trophoblastic neoplasia. Acta Obstet Gynecol Scand 75(6):548–550. doi:10.3109/00016349609054669 PubMedCrossRefGoogle Scholar
  5. 5.
    Soper JT, Hammond CB (1987) Role of surgical therapy and radiotherapy in gestational trophoblastic disease. J Reprod Med 32(9):663–668PubMedGoogle Scholar
  6. 6.
    Semple PL, Denny L, Coughlan M, Soeters R, Van Wijk L (2004) The role of neurosurgery in the treatment of cerebral metastases from choriocarcinoma: a report of two cases. Int J Gynecol Cancer 14(1):157–161. doi:10.1111/j.1048-891x.2004.14147.x PubMedCrossRefGoogle Scholar
  7. 7.
    Lurain JR (1998) Management of high-risk gestational trophoblastic disease. J Reprod Med 43(1):44–52PubMedGoogle Scholar
  8. 8.
    Baertschi E, Notter M, Mironov A, Wernli M, Bargetzi MJ (2003) Cerebral metastasis in choriocarcinoma a case report. Schweiz Rundsch Med Prax 92(16):763–768Google Scholar
  9. 9.
    Amr MF (1999) Return of fertility after successful chemotherapy treatment of gestational trophoblastic tumors. Int J Fertil Womens Med 44(3):146–149PubMedGoogle Scholar
  10. 10.
    Soper JT, Spillman M, Sampson JH, Kirkpatrick JP, Wolf JK, Clarke-Pearson DL (2007) High-risk gestational trophoblastic neoplasia with brain metastases: individualized multidisciplinary therapy in the management of four patients. Gynecol Oncol 104(3):691–694. doi:10.1016/j.ygyno.2006.10.027 PubMedCrossRefGoogle Scholar
  11. 11.
    Ghaemmaghami F, Modares M, Arab M, Behtash N, Moosavi AZ, Khanafshar N, Hanjani P (2004) EMA-EP regimen, as firstline multiple agent chemotherapy in high-risk GTT patients (stage II–IV). Int J Gynecol Cancer 14(2):360–365PubMedCrossRefGoogle Scholar
  12. 12.
    Bower M, Rustin GJ, Newlands ES, Holden L, Short D, Foskett M et al (1998) Chemotherapy for gestational trophoblastic tumours hastens menopause by 3 years. Eur J Cancer 34(8):1204–1207. doi:10.1016/S0959-8049(98)00059-8 PubMedCrossRefGoogle Scholar
  13. 13.
    Suzuki I, Goto S, Yamada A, Tomoda Y (1993) Pregnancy after chemotherapy for trophoblastic diseases and psychosomatic development in the progeny. Asia Oceania J Obstet Gynaecol 19(4):407–415PubMedGoogle Scholar
  14. 14.
    Goto S, Ino K, Mitsui T, Kikkawa F, Suzuki T, Nomura S et al (2004) Survival rates of patients with choriocarcinoma treated with chemotherapy without hysterectomy: effects of anticancer agents on subsequent births. Gynecol Oncol 93(2):529–535. doi:10.1016/j.ygyno.2004.02.018 PubMedCrossRefGoogle Scholar
  15. 15.
    Yokota H, Mabuchi Y, Hosomichi T, Kimura M, Imai H, Sutou K (1993) A case of successful pregnancy and delivery after brain metastasis of choriocarcinoma. Asia Oceania J Obstet Gynaecol 19(1):29–35PubMedGoogle Scholar
  16. 16.
    Huang CY, Chen CA, Hsieh CY, Cheng WF (2007) Intracerebral hemorrhage as initial presentation of gestational choriocarcinoma: a case report and literature review. Int J Gynecol Cancer 17(5):1166–1171PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2008

Authors and Affiliations

  • Nadereh Behtash
    • 1
  • Fariba Behnamfar
    • 2
  • Bahareh Hamedi
    • 3
  • Fatemeh Ramezanzadeh
    • 4
  1. 1.Gynecology Oncology Department, Vali-e-Asr HospitalTehran University of Medical SciencesTehranIran
  2. 2.Kashan University of Medical SciencesKashanIran
  3. 3.Gynecology Obstetrics ResidentTehran University of Medical SciencesTehranIran
  4. 4.Obstetrics Gynecology, Vali-e-Asr Reproductive Health Research CenterTehran University of Medical SciencesTehranIran

Personalised recommendations